Severe Eosinophilic Asthma

Disease State Hub

Quizzes

Pop Quiz

Assessing Symptom Improvement with Azithromycin in Severe Asthma

04/21/2015

Anthony Calabro, MA

Azithromycin may offer added benefit for patients with severe asthma who continue to experience exacerbations despite biologic therapy. Which outcome best reflects its impact on asthma control in this...

04/21/2015

Research Summaries

Research Summary

Research Summary

Azithromycin Reduces Residual Exacerbations in Biologic-Treated Severe Asthma: A Single-Center Audit

09/23/2025

Anthony Calabro, MA

In patients with severe asthma who experience persistent exacerbations despite biologic therapy, azithromycin reduced both steroid- and antibiotic-requiring events and improved symptom control, according to...

09/23/2025

research summary

research summary

Exacerbations Increased After Discontinuing Long-term Use of Mepolizumab for Severe Eosinophilic Asthma

08/19/2022

While the long-term safety and efficacy of mepolizumab have been studied, gaps in the literature have remained on the clinical impact of stopping mepolizumab after long-term use. Researchers examined how...

08/19/2022

asthma

FDA Approves New Option for Severe Eosinophilic Asthma

11/15/2017

The FDA has approved a new add-on maintenance treatment option for patients with severe asthma with eosinophilic phenotype.

11/15/2017

April 2026

Current Issue

April 2026